Russia has assured India that it will deliver 100 million doses of Sputnik-V, the Kovid-19 vaccine. Indian pharmaceutical company Dr. Russia’s Sovereign Asset Fund has agreed to deliver 100 million doses of Sputnik-V to Reddy’s laboratories. Russia has accelerated plans to distribute the vaccine abroad.
The agreement was reached after the Russian Direct Investment Fund (RDF) reached an agreement with Indian manufacturers to produce 300 million doses of the vaccine in India, a major consumer of Russian oil and weapons. One of the best pharmaceutical companies in India, Dr. The RDF said in a statement that the regulatory approval for the third phase of clinical trials of Reddy’s vaccines would not be available in India.
Deliveries to India are expected to start by the end of 2020, subject to completion of trials and registration of the vaccine by regulatory authorities in India, the report said. Russia was the first country to license the coronavirus vaccine before the completion of the third phase of large-scale trials. But scientists and doctors have expressed concern about the safety and effectiveness of wax.
At the same time, the result of the second phase of the first phase of Kovid Wax is also positive. GV Prasad, co-chairman of Reddy, said in an RDF statement. He said that Sputnik V will help give us a reliable option in our fight against Kovid in India. At first there was no information about the price of vaccines. But the RDF had previously said that it was important not to make a profit and therefore only charge for the cost of the drug.
RDF has already entered into vaccine distribution deals with Kazakhstan, Brazil and Mexico. It has also signed a memorandum of understanding with the Saudi Chemical Company.